| Tammy S Mccarthy, MA, LMFT | |
|
11010 Prairie Lakes Dr Ste 350, Eden Prairie, MN 55344-3801 | |
| (952) 746-2522 | |
| (952) 746-0887 |
| Full Name | Tammy S Mccarthy |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 11010 Prairie Lakes Dr Ste 350, Eden Prairie, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629400833 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 2715 (Minnesota) | Primary |
| Entity Name | Carver County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326049685 PECOS PAC ID: 8527041961 Enrollment ID: O20040609000094 |
News Archive
Four of five newborn infants who experience a stroke around the time of birth will develop neurologic disorders such as cerebral palsy, epilepsy, or language delay, according to a study published online July 11, 2005, in the Annals of Neurology.
Ajinomoto AminoScience LLC (AAS) today announced that it has confirmed GRAS (Generally Recognized As Safe) status of its AjiGRAS-Leucine, meeting the safety standards demanded by the US Food and Drug Administration (FDA). As the only formulation of Leucine currently with FDA acknowledged GRAS status, Ajinomoto's AjiGRAS-Leucine is the first amino acid to be allowed as an ingredient for use in conventional foods like non-milk and milk based meal replacements, sports and isotonic beverages, vitamin enhanced waters, and meal replacement bars, at levels of 0.5 to 3 grams per serving.
Bruker announced today that it has successfully installed its BioSpec® 170/25 system at the CEA NeuroSpin research center near Paris, France. The world's first horizontal ultra-high magnetic field 17.2 Tesla MRI system features a magnet bore diameter of 25 cm. It is equipped with a novel Bruker BGA-S™ gradient system with unsurpassed amplitude and slew rate specifications for cutting-edge preclinical in vivo imaging on small animals.
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tammy S Mccarthy, MA, LMFT 1900 Silver Lake Rd Nw, Suite 115, New Brighton, MN 55112-1786 Ph: (651) 628-9566 | Tammy S Mccarthy, MA, LMFT 11010 Prairie Lakes Dr Ste 350, Eden Prairie, MN 55344-3801 Ph: (952) 746-2522 |
News Archive
Four of five newborn infants who experience a stroke around the time of birth will develop neurologic disorders such as cerebral palsy, epilepsy, or language delay, according to a study published online July 11, 2005, in the Annals of Neurology.
Ajinomoto AminoScience LLC (AAS) today announced that it has confirmed GRAS (Generally Recognized As Safe) status of its AjiGRAS-Leucine, meeting the safety standards demanded by the US Food and Drug Administration (FDA). As the only formulation of Leucine currently with FDA acknowledged GRAS status, Ajinomoto's AjiGRAS-Leucine is the first amino acid to be allowed as an ingredient for use in conventional foods like non-milk and milk based meal replacements, sports and isotonic beverages, vitamin enhanced waters, and meal replacement bars, at levels of 0.5 to 3 grams per serving.
Bruker announced today that it has successfully installed its BioSpec® 170/25 system at the CEA NeuroSpin research center near Paris, France. The world's first horizontal ultra-high magnetic field 17.2 Tesla MRI system features a magnet bore diameter of 25 cm. It is equipped with a novel Bruker BGA-S™ gradient system with unsurpassed amplitude and slew rate specifications for cutting-edge preclinical in vivo imaging on small animals.
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
› Verified 1 days ago
Ms. Cindy Kay Lea, MA, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 11800 Singletree Ln, Suite 204, Eden Prairie, MN 55344 Phone: 612-965-3052 | |
Wa S Cheng-berg, MA, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 11010 Prairie Lakes Dr Ste 350, Eden Prairie, MN 55344 Phone: 952-746-2522 Fax: 952-746-0887 | |
Michelle Nicole Iversen, MA, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 11010 Prairie Lakes Dr Ste 350, Eden Prairie, MN 55344 Phone: 952-746-2522 | |
Mrs. Asha Isse, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7550 Market Place Dr Ste 3, Eden Prairie, MN 55344 Phone: 651-299-0044 | |
Mrs. Briana Jo Freeberg, MA, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 6458 City W Pkwy, Eden Prairie, MN 55344 Phone: 651-815-2045 | |
Ms. Dawn N Ramaker, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 6542 Regency Ln, Suite 202, Eden Prairie, MN 55344 Phone: 952-903-9202 | |
Christa Rose Erickson, Couples Therapy Medicare: Medicare Enrolled Practice Location: 6458 City West Pkwy, Eden Prairie, MN 55344 Phone: 952-767-5900 |